Ligand validation:6C4D

EJP: (3S)-3-(2-benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile

EJP is a Ligand Of Interest in 6C4D designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6C4D_EJP_D_1100	72%	41%	0.118	0.942	0.96	1.4	2	3	0	0	100%	1
6C4D_EJP_C_1100	69%	40%	0.14	0.957	1.01	1.39	2	3	0	0	100%	1
6C4D_EJP_B_1100	69%	43%	0.147	0.964	0.98	1.29	2	2	0	0	100%	1
6C4D_EJP_A_1100	56%	41%	0.174	0.947	0.99	1.33	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.